Scientific Session
Systemic lupus erythematosus (SLE)
David Isenberg, MD, FRCP
University College London
London, United Kingdom
Disclosure: Disclosure(s): Amgen: Advisor or Review Panel Member (Ongoing); Astra Zeneca: Advisor or Review Panel Member (Ongoing); Glaxo Smith Kline: Advisor or Review Panel Member (Terminated); Servier: Advisor or Review Panel Member (Ongoing); UCB Pharma: Advisor or Review Panel Member (Ongoing)